JP2023548190A5 - - Google Patents
Info
- Publication number
- JP2023548190A5 JP2023548190A5 JP2023527016A JP2023527016A JP2023548190A5 JP 2023548190 A5 JP2023548190 A5 JP 2023548190A5 JP 2023527016 A JP2023527016 A JP 2023527016A JP 2023527016 A JP2023527016 A JP 2023527016A JP 2023548190 A5 JP2023548190 A5 JP 2023548190A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- mutation
- leukemia
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0147156 | 2020-11-05 | ||
| KR20200147156 | 2020-11-05 | ||
| PCT/KR2021/015794 WO2022098083A1 (ko) | 2020-11-05 | 2021-11-03 | Flt3 억제제를 포함하는 백혈병 치료용 약학적 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023548190A JP2023548190A (ja) | 2023-11-15 |
| JP2023548190A5 true JP2023548190A5 (https=) | 2024-11-12 |
| JP7842752B2 JP7842752B2 (ja) | 2026-04-08 |
Family
ID=81458079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527016A Active JP7842752B2 (ja) | 2020-11-05 | 2021-11-03 | 骨髄性白血病の治療のためのｆｌｔ３阻害剤を含む医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20260102397A1 (https=) |
| EP (1) | EP4241773A4 (https=) |
| JP (1) | JP7842752B2 (https=) |
| KR (1) | KR20220061026A (https=) |
| CN (1) | CN116583284A (https=) |
| CA (1) | CA3197836A1 (https=) |
| TW (1) | TW202233193A (https=) |
| WO (1) | WO2022098083A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101954370B1 (ko) | 2018-07-25 | 2019-03-05 | 한미약품 주식회사 | 피리미딘 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물 |
| BR112021016522A2 (pt) | 2019-02-22 | 2021-10-26 | Hanmi Pharm. Co., Ltd. | Composição farmacêutica para o tratamento da leucemia mieloide aguda |
| EA202290154A1 (ru) | 2019-06-27 | 2022-03-29 | Ханми Фарм. Ко., Лтд. | Фармацевтическая композиция для лечения острого миелоидного лейкоза, содержащая ингибитор flt3 и химиотерапевтические агенты |
| CN117586344B (zh) * | 2022-08-12 | 2025-07-25 | 上海交通大学医学院附属瑞金医院 | 靶向flt3-d835突变的抗原肽及其在肿瘤免疫治疗中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0500492D0 (en) * | 2005-01-11 | 2005-02-16 | Cyclacel Ltd | Compound |
| US20110183975A1 (en) * | 2008-10-07 | 2011-07-28 | Yasuhiro Goto | Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity |
| CN110229142A (zh) * | 2014-04-04 | 2019-09-13 | 希洛斯医药品股份有限公司 | 细胞周期蛋白依赖性激酶7(cdk7)的抑制剂 |
| KR102110573B1 (ko) * | 2015-08-13 | 2020-05-13 | 베이징 한미 파마슈티컬 컴퍼니 리미티드 | Irak4억제제 및 이의 용도 |
| KR101954370B1 (ko) * | 2018-07-25 | 2019-03-05 | 한미약품 주식회사 | 피리미딘 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물 |
| KR20200102948A (ko) * | 2019-02-22 | 2020-09-01 | 한미약품 주식회사 | Flt3 저해제 및 iap 길항제를 포함하는 급성 골수성 백혈병의 치료를 위한 약학적 조합물 |
-
2021
- 2021-11-03 EP EP21889548.0A patent/EP4241773A4/en active Pending
- 2021-11-03 WO PCT/KR2021/015794 patent/WO2022098083A1/ko not_active Ceased
- 2021-11-03 US US18/251,827 patent/US20260102397A1/en active Pending
- 2021-11-03 JP JP2023527016A patent/JP7842752B2/ja active Active
- 2021-11-03 CN CN202180084028.6A patent/CN116583284A/zh active Pending
- 2021-11-03 KR KR1020210149894A patent/KR20220061026A/ko active Pending
- 2021-11-03 CA CA3197836A patent/CA3197836A1/en active Pending
- 2021-11-04 TW TW110141175A patent/TW202233193A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023548190A5 (https=) | ||
| JP2022515198A5 (https=) | ||
| CN113767106A (zh) | 氧杂氮杂喹唑啉-7(8h)-酮类化合物,其制法与医药上的用途 | |
| JP2006523216A5 (https=) | ||
| JP2022141916A5 (https=) | ||
| JP2020519661A5 (https=) | ||
| JP2022538817A5 (https=) | ||
| JP2020023528A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| TW201127378A (en) | Benzimidazole-imidazole derivatives | |
| JP2006182786A5 (https=) | ||
| JP2018534286A5 (https=) | ||
| JP2010532768A5 (https=) | ||
| JP2019515908A5 (https=) | ||
| JP2017531619A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| CN102753176B (zh) | 含有cdc7抑制剂和抗癌药的治疗组合物 | |
| JP2020097596A5 (https=) | ||
| JP2024516795A5 (https=) | ||
| US10561647B2 (en) | Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof | |
| JP2024520630A5 (https=) | ||
| JP2023522166A5 (https=) | ||
| JP2012522841A5 (https=) | ||
| JP2023550149A5 (https=) | ||
| JP2014507412A5 (https=) |